Regulation of Bcl-2 protein expression in human neuroblastoma SH-SY5Y cells

Positive and negative effects of protein kinases C and A, respectively

Yasuhiro Itano, Akihiro Ito, Takashi Uehara, Yasuyuki Nomura

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

The regulatory mechanism of Bcl-2 protein expression was investigated in SH-SY5Y cells, the human neuroblastoma cell line that expresses natively Bcl- 2 proteins. When the cells were treated with 12-O-tetradecanoylphorbol 13- acetate (TPA) or retinoic acid, the level of Bcl-2 protein was increased compared with the control. These effects were inhibited by pretreatment with a protein kinase C (PKC) inhibitor, staurosporine or calphostin C. The level of Bcl-2 protein was also increased by treatment with carbachol, a muscarinic acetylcholine receptor (mAChR) agonist, and the effects were also inhibited by pretreatment with staurosporine or calphostin C. In addition, a carbachol- induced increase in Bcl-2 protein levels and a transient elevation of [Ca2+](i) were inhibited by pretreatment with 4-DAMP (4-diphenylacetoxy-N- methylpiperidine), an m3 mAChR antagonist. In contrast, the level of Bcl-2 protein was decreased by treatment with dibutyryl cAMP (diBu-cAMP), forskolin, or cholera toxin, and the effects of diBu-cAMP were inhibited by pretreatment with a protein kinase A (PKA) inhibitor, H-89. From these results, we suggest that the expression of Bcl-2 proteins is regulated by PKC and PKA in positive and negative manners, respectively, in SH-SY5Y cells. Furthermore, the nucleosomal DNA fragmentation induced by serum depletion for 4 h was observed in SH-SY5Y cells when the level of Bcl-2 protein was down- regulated by treatment with 1 mM diBu-cAMP for 3 days, although the DNA fragmentation by serum depletion for 4 h was not observed in nontreatment cells, indicating that Bcl-2 proteins whose expression is regulated by PKC and PKA play important roles in serum depletion-induced apoptosis.

Original languageEnglish
Pages (from-to)131-137
Number of pages7
JournalJournal of Neurochemistry
Volume67
Issue number1
Publication statusPublished - Jul 1996
Externally publishedYes

Fingerprint

Staphylococcal Protein A
Neuroblastoma
Protein Kinase C
Proteins
Cyclic AMP-Dependent Protein Kinases
Staurosporine
Carbachol
Muscarinic Receptors
DNA Fragmentation
Protein Kinase Inhibitors
Serum
Cholinergic Agonists
Protein C Inhibitor
Cholera Toxin
DNA
Cholinergic Antagonists
Tetradecanoylphorbol Acetate
Colforsin
Tretinoin
Acetates

Keywords

  • Apoptosis
  • Bcl-2
  • Protein kinase A
  • Protein kinase C
  • SH-SY5Y cells

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

Regulation of Bcl-2 protein expression in human neuroblastoma SH-SY5Y cells : Positive and negative effects of protein kinases C and A, respectively. / Itano, Yasuhiro; Ito, Akihiro; Uehara, Takashi; Nomura, Yasuyuki.

In: Journal of Neurochemistry, Vol. 67, No. 1, 07.1996, p. 131-137.

Research output: Contribution to journalArticle

@article{4079b03a4b0a4c8f8578ea40370d0d98,
title = "Regulation of Bcl-2 protein expression in human neuroblastoma SH-SY5Y cells: Positive and negative effects of protein kinases C and A, respectively",
abstract = "The regulatory mechanism of Bcl-2 protein expression was investigated in SH-SY5Y cells, the human neuroblastoma cell line that expresses natively Bcl- 2 proteins. When the cells were treated with 12-O-tetradecanoylphorbol 13- acetate (TPA) or retinoic acid, the level of Bcl-2 protein was increased compared with the control. These effects were inhibited by pretreatment with a protein kinase C (PKC) inhibitor, staurosporine or calphostin C. The level of Bcl-2 protein was also increased by treatment with carbachol, a muscarinic acetylcholine receptor (mAChR) agonist, and the effects were also inhibited by pretreatment with staurosporine or calphostin C. In addition, a carbachol- induced increase in Bcl-2 protein levels and a transient elevation of [Ca2+](i) were inhibited by pretreatment with 4-DAMP (4-diphenylacetoxy-N- methylpiperidine), an m3 mAChR antagonist. In contrast, the level of Bcl-2 protein was decreased by treatment with dibutyryl cAMP (diBu-cAMP), forskolin, or cholera toxin, and the effects of diBu-cAMP were inhibited by pretreatment with a protein kinase A (PKA) inhibitor, H-89. From these results, we suggest that the expression of Bcl-2 proteins is regulated by PKC and PKA in positive and negative manners, respectively, in SH-SY5Y cells. Furthermore, the nucleosomal DNA fragmentation induced by serum depletion for 4 h was observed in SH-SY5Y cells when the level of Bcl-2 protein was down- regulated by treatment with 1 mM diBu-cAMP for 3 days, although the DNA fragmentation by serum depletion for 4 h was not observed in nontreatment cells, indicating that Bcl-2 proteins whose expression is regulated by PKC and PKA play important roles in serum depletion-induced apoptosis.",
keywords = "Apoptosis, Bcl-2, Protein kinase A, Protein kinase C, SH-SY5Y cells",
author = "Yasuhiro Itano and Akihiro Ito and Takashi Uehara and Yasuyuki Nomura",
year = "1996",
month = "7",
language = "English",
volume = "67",
pages = "131--137",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Regulation of Bcl-2 protein expression in human neuroblastoma SH-SY5Y cells

T2 - Positive and negative effects of protein kinases C and A, respectively

AU - Itano, Yasuhiro

AU - Ito, Akihiro

AU - Uehara, Takashi

AU - Nomura, Yasuyuki

PY - 1996/7

Y1 - 1996/7

N2 - The regulatory mechanism of Bcl-2 protein expression was investigated in SH-SY5Y cells, the human neuroblastoma cell line that expresses natively Bcl- 2 proteins. When the cells were treated with 12-O-tetradecanoylphorbol 13- acetate (TPA) or retinoic acid, the level of Bcl-2 protein was increased compared with the control. These effects were inhibited by pretreatment with a protein kinase C (PKC) inhibitor, staurosporine or calphostin C. The level of Bcl-2 protein was also increased by treatment with carbachol, a muscarinic acetylcholine receptor (mAChR) agonist, and the effects were also inhibited by pretreatment with staurosporine or calphostin C. In addition, a carbachol- induced increase in Bcl-2 protein levels and a transient elevation of [Ca2+](i) were inhibited by pretreatment with 4-DAMP (4-diphenylacetoxy-N- methylpiperidine), an m3 mAChR antagonist. In contrast, the level of Bcl-2 protein was decreased by treatment with dibutyryl cAMP (diBu-cAMP), forskolin, or cholera toxin, and the effects of diBu-cAMP were inhibited by pretreatment with a protein kinase A (PKA) inhibitor, H-89. From these results, we suggest that the expression of Bcl-2 proteins is regulated by PKC and PKA in positive and negative manners, respectively, in SH-SY5Y cells. Furthermore, the nucleosomal DNA fragmentation induced by serum depletion for 4 h was observed in SH-SY5Y cells when the level of Bcl-2 protein was down- regulated by treatment with 1 mM diBu-cAMP for 3 days, although the DNA fragmentation by serum depletion for 4 h was not observed in nontreatment cells, indicating that Bcl-2 proteins whose expression is regulated by PKC and PKA play important roles in serum depletion-induced apoptosis.

AB - The regulatory mechanism of Bcl-2 protein expression was investigated in SH-SY5Y cells, the human neuroblastoma cell line that expresses natively Bcl- 2 proteins. When the cells were treated with 12-O-tetradecanoylphorbol 13- acetate (TPA) or retinoic acid, the level of Bcl-2 protein was increased compared with the control. These effects were inhibited by pretreatment with a protein kinase C (PKC) inhibitor, staurosporine or calphostin C. The level of Bcl-2 protein was also increased by treatment with carbachol, a muscarinic acetylcholine receptor (mAChR) agonist, and the effects were also inhibited by pretreatment with staurosporine or calphostin C. In addition, a carbachol- induced increase in Bcl-2 protein levels and a transient elevation of [Ca2+](i) were inhibited by pretreatment with 4-DAMP (4-diphenylacetoxy-N- methylpiperidine), an m3 mAChR antagonist. In contrast, the level of Bcl-2 protein was decreased by treatment with dibutyryl cAMP (diBu-cAMP), forskolin, or cholera toxin, and the effects of diBu-cAMP were inhibited by pretreatment with a protein kinase A (PKA) inhibitor, H-89. From these results, we suggest that the expression of Bcl-2 proteins is regulated by PKC and PKA in positive and negative manners, respectively, in SH-SY5Y cells. Furthermore, the nucleosomal DNA fragmentation induced by serum depletion for 4 h was observed in SH-SY5Y cells when the level of Bcl-2 protein was down- regulated by treatment with 1 mM diBu-cAMP for 3 days, although the DNA fragmentation by serum depletion for 4 h was not observed in nontreatment cells, indicating that Bcl-2 proteins whose expression is regulated by PKC and PKA play important roles in serum depletion-induced apoptosis.

KW - Apoptosis

KW - Bcl-2

KW - Protein kinase A

KW - Protein kinase C

KW - SH-SY5Y cells

UR - http://www.scopus.com/inward/record.url?scp=0029933694&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029933694&partnerID=8YFLogxK

M3 - Article

VL - 67

SP - 131

EP - 137

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 1

ER -